Norges Bank Allogene Therapeutics, Inc. Transaction History

Norges Bank

$716 Trillion
Q3 2024

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$2.28 - $3.5 $617,355 - $947,695	270,770 New	270,770 $869,000
Q3 2023 Nov 13, 2024	BUY	$3.17 - $5.96 $2.06 Million - $3.87 Million	650,072 New	650,072 $2.06 Million
Q3 2023 Nov 13, 2023	SELL	$3.17 - $5.96 $2.93 Million - $5.5 Million	-923,009 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$4.53 - $6.74 $3.48 Million - $5.18 Million	769,120 New	769,120 $3.82 Million
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $4.18 Million - $6.22 Million	-923,009 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$4.92 - $8.21 $3.78 Million - $6.31 Million	769,120 New	769,120 $3.8 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $11.11 $4.97 Million - $9.82 Million	883,947 New	883,947 $5.56 Million
Q3 2022 Nov 13, 2023	BUY	$10.32 - $17.28 $9.53 Million - $15.9 Million	923,009 New	923,009 $9.97 Million
Q2 2022 Aug 14, 2023	BUY	$6.78 - $12.28 $6.26 Million - $11.3 Million	923,009 New	923,009 $10.5 Million
Q1 2022 May 12, 2023	BUY	$7.65 - $15.29 $9.1 Million - $18.2 Million	1,189,570 Added 134.57%	2,073,517 $18.9 Million
Q1 2022 May 09, 2022	SELL	$7.65 - $15.29 $12.5 Million - $24.9 Million	-1,629,417 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$13.13 - $24.52 $21.4 Million - $40 Million	1,629,417 New	1,629,417 $24.3 Million
Q3 2021 Nov 14, 2022	BUY	$21.01 - $27.64 $24.7 Million - $32.5 Million	1,175,996 New	1,175,996 $30.2 Million
Q3 2021 Nov 05, 2021	SELL	$21.01 - $27.64 $33 Million - $43.4 Million	-1,570,629 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$23.49 - $35.8 $36.9 Million - $56.2 Million	1,570,629 New	1,570,629 $41 Million
Q2 2021 Aug 10, 2021	SELL	$23.49 - $35.8 $22.6 Million - $34.4 Million	-960,171 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$25.79 - $39.02 $24.8 Million - $37.5 Million	960,171 New	960,171 $33.9 Million
Q1 2021 May 07, 2021	SELL	$25.79 - $39.02 $29.3 Million - $44.3 Million	-1,136,208 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$25.24 - $43.45 $28.7 Million - $49.4 Million	1,136,208 New	1,136,208 $28.7 Million
Q4 2020 Feb 10, 2021	SELL	$25.24 - $43.45 $31.1 Million - $53.5 Million	-1,231,092 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$32.38 - $44.96 $39.9 Million - $55.3 Million	1,231,092 New	1,231,092 $46.4 Million
Q3 2020 Nov 10, 2020	SELL	$32.38 - $44.96 $45.4 Million - $63 Million	-1,402,031 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$18.39 - $54.04 $25.8 Million - $75.8 Million	1,402,031 New	1,402,031 $60 Million
Q2 2020 Aug 07, 2020	SELL	$18.39 - $54.04 $19.2 Million - $56.5 Million	-1,044,833 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$18.22 - $28.25 $19 Million - $29.5 Million	1,044,833 New	1,044,833 $20.3 Million
Q1 2020 May 08, 2020	SELL	$18.22 - $28.25 $19.4 Million - $30.1 Million	-1,064,580 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$24.82 - $31.4 $26.4 Million - $33.4 Million	1,064,580 New	1,064,580 $27.7 Million
Q4 2019 Feb 12, 2020	SELL	$24.82 - $31.4 $25.2 Million - $31.9 Million	-1,016,463 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$26.11 - $32.99 $26.5 Million - $33.5 Million	1,016,463 New	1,016,463 $27.7 Million
Q3 2019 Nov 08, 2019	SELL	$26.11 - $32.99 $19.3 Million - $24.4 Million	-740,840 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$25.56 - $31.09 $18.9 Million - $23 Million	740,840 New	740,840 $19.9 Million
Q2 2019 Aug 09, 2019	SELL	$25.56 - $31.09 $10.2 Million - $12.4 Million	-400,000 Closed	0 $0
Q4 2018 Mar 04, 2019	BUY	$22.5 - $33.3 $9 Million - $13.3 Million	400,000 New	400,000 $10.8 Million

Others Institutions Holding ALLO

# of Institutions

166

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $217M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account